Page last updated: 2024-11-02

piretanide and Uremia

piretanide has been researched along with Uremia in 2 studies

piretanide: potent inhibitor of chloride transport; structure

Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.

Research Excerpts

ExcerptRelevanceReference
" Pharmacokinetic data showed rapid and almost complete absorption (bioavailability 92%) and a rapid elimination with renal clearance of 50% of the total 200 ml/min in the normals and renal clearance of about 50% of actual GFR in the patients."1.27Pharmacokinetic-pharmacodynamic relationship of piretanide in healthy and uremic subjects. Determinants of the diuretic effect of a loop diuretic. ( Beermann, B; Odlind, B; Sjöström, P, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elliott, HL1
Ansari, AF1
Campbell, BC1
Lawrence, JR1
Sjöström, P1
Beermann, B1
Odlind, B1

Other Studies

2 other studies available for piretanide and Uremia

ArticleYear
Protein binding of piretanide in normal and uraemic serum.
    European journal of clinical pharmacology, 1982, Volume: 21, Issue:4

    Topics: Blood Proteins; Diuretics; Humans; Protein Binding; Serum Albumin; Sulfonamides; Ultrafiltration; Ur

1982
Pharmacokinetic-pharmacodynamic relationship of piretanide in healthy and uremic subjects. Determinants of the diuretic effect of a loop diuretic.
    Scandinavian journal of urology and nephrology, 1987, Volume: 21, Issue:1

    Topics: Adult; Aged; Biological Availability; Diuresis; Dose-Response Relationship, Drug; Female; Humans; Ki

1987